Drug Research
Lonza Launches Nebula Absorbance Reader for Streamlined Endotoxin and Pyrogen Testing
Lonza has launched the Nebula® Absorbance Reader, a new absorbance microplate reader which joins the company’s portfolio of optimized instruments for streamlined endotoxin and pyrogen testing.
Pharmaceutical quality control (QC) laboratories worldwide rely on the traditional absorbance-based Limulus amebocyte lysate (LAL) and Tachypleus amebocyte...
Drug Research
Emerging Markets Drive Small Molecule API Market Expansion
As per insights, a significant increase in the small molecule active pharmaceutical ingredient (API) market has been projected, estimating it to be valued at approximately $284.7 billion by 2032, compared to $162.8 billion in 2022. A compound annual growth...
Drug Research
Startups Tackle Efficiency Woes In The Pharma Supply Chain
The healthcare industry is responsible for 4.4% of all greenhouse gas emissions and faces significant challenges in its supply chain, resulting in $35 billion worth of wasted products each year. Startups have emerged as powerful agents of change, leveraging...
Drug Research
Pharma Supply Chains: From Globalization To Regional Hubs
Overseeing a pharmaceutical supply chain and ensuring its efficiency is a complex and collaborative endeavor. The process commences with sourcing raw materials, including chemicals and ingredients, which are used to manufacture drugs. These drugs undergo stringent quality checks, formulation,...
Drug Research
UHPT Method In NMR Benefits Natural Product Bio Industry
In the late 1950s and 1960s, thalidomide, a drug given to pregnant women to alleviate morning sickness, caused a tragic outcome. Over 12,000 babies were born with severe malformations, like shortened limbs, due to the drug's side effects. These...
Drug Research
Upperton completes build of new £15m development and GMP manufacturing facility
Leading UK contract development and manufacturing organisation (CDMO), Upperton Pharma Solutions has completed the build of its new development and GMP manufacturing headquarters in Nottingham, UK.
Situated less than two miles from Upperton’s current HQ, the facility houses ten new...
BioPharma
Overcoming Treatment Challenges With Cell And Gene Therapies
Gene and cell therapies have the potential to revolutionize healthcare by reprogramming the immune system to treat diseases that are difficult to address with traditional medicine. These therapies involve introducing, replacing, or deactivating genes in cells, either inside or...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read














